| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.46B | 34.41B | 40.55B | 55.38B | 39.73B | 29.55B |
| Gross Profit | 4.15B | 4.67B | 4.12B | 4.23B | 3.99B | 4.88B |
| EBITDA | 1.44B | 2.05B | 1.46B | 1.77B | 1.23B | 2.38B |
| Net Income | 1.25B | 335.00M | 1.27B | 625.00M | 329.00M | 1.34B |
Balance Sheet | ||||||
| Total Assets | 64.50B | 66.54B | 69.32B | 76.83B | 61.13B | 52.53B |
| Cash, Cash Equivalents and Short-Term Investments | 9.12B | 6.10B | 10.32B | 6.59B | 7.88B | 12.34B |
| Total Debt | 14.99B | 13.21B | 19.69B | 21.58B | 12.89B | 9.29B |
| Total Liabilities | 32.61B | 31.55B | 37.49B | 43.76B | 31.26B | 22.98B |
| Stockholders Equity | 31.88B | 34.99B | 31.83B | 32.53B | 29.38B | 29.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.27B | 3.73B | -9.72B | -7.60B | 4.61B |
| Operating Cash Flow | 0.00 | 4.72B | 8.18B | -8.58B | -6.50B | 4.82B |
| Investing Cash Flow | 0.00 | -1.94B | -869.00M | -146.00M | -643.00M | 37.00M |
| Financing Cash Flow | 0.00 | -7.00B | -3.59B | 7.43B | 2.68B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥6.86B | 14.94 | ― | 3.77% | 10.82% | 30.60% | |
70 Outperform | ¥7.77B | 14.33 | ― | 2.03% | 26.86% | 0.06% | |
65 Neutral | ¥15.61B | 15.50 | ― | 1.39% | -1.70% | 409.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥8.19B | -18.96 | ― | 4.94% | -1.88% | -179.98% | |
54 Neutral | ¥10.01B | 30.08 | ― | 3.74% | -15.14% | -73.61% | |
50 Neutral | ¥7.15B | -11.34 | ― | 4.38% | -22.48% | -263.36% |